Tag: CIIX

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Establishing Strong Position in Chinese CBD-Based Nutrition, Health-Product Market

ChineseInvestors.com (OTCQB: CIIX), a financial news and investment portal for the global Chinese-speaking community, is establishing itself as a major player in the emerging CBD market for CBD-based nutrition and health products in China. An article discussing the company reads, “Through wholly owned enterprise CBD Biotech Inc., CIIX is implementing its CBD initiatives. At present, CIIX is at the vanguard of what may become be the globe’s largest CBD market: China (www.CIIXInfo.com). The company recognizes the untapped CBD market for Chinese-speaking individuals, specifically in the health-care sector, which is expected to grow by as much as 10% per year. Due to a higher spending power from consumers, China’s demand for medicinal products such as those made from hemp-based CBD has risen. Analysts foresee China’s CBD market reaching over $20 billion by 2022, and CIIX is uniquely positioned to meet this consumer demand. CIIX is hoping for a Nasdaq IPO of CBD Biotech late in FY2019 or early in 2020.”

To view the full article, visit http://cnw.fm/M0My1

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Colorado Supreme Court to Decide on Medical Marijuana Rights of People on Probation

Is it fair for people on probation to present additional proof of their need for medical marijuana to judges? The Colorado Supreme Court is set to make a decision on this matter. This comes after Alysha Walton agreed to probation after she was arrested for speeding and driving under the influence and pleaded guilty in El Paso County in 2017. Her lawyer requested a hearing where he argued that she be allowed to continue receiving medical marijuana while serving her sentence, but the judge said that her doctor would have to testify.

Data from the Department of Public Health and Environment in Colorado shows that there are at least 80,000 people who have valid medical marijuana cards, and a quarter of these are patients from El Paso County. Therefore, it is hard to predict how many people have issues with these kinds of stipulations as conditions for those on probation.

No doctor was willing to testify on her behalf; therefore, Walton appeared at her hearing with only her medical card and a letter from a doctor despite being advised otherwise by the court. Eventually, the court ruled against her, and she was required to stop using medical marijuana during her probation. The Colorado Public Defenders office argued that the restriction was an abuse of the court’s power by the judge since she presented the documentation needed to support her need for medical marijuana.

According to Jay Tiftickjian, a law allowing people on probation to use medical marijuana was passed in 2015, although it is still not clear to what extent this law is being implemented because he still gets countless emails from people on probation requiring to use medical marijuana but are not allowed. Due to the colossal amount of inquiries, his firm added a page to their website for answering some of the common questions.

According to Tiftickjian, a judge’s view on weed can affect his decision where one judge may permit the use of medical cannabis while another may issue a strict sentence when asked for permission to seek medical marijuana treatment.

Tiftickjian had a client, John West, who was arrested for driving under the influence of alcohol in Jefferson County. The Judge gave West two options, either give up driving or retain his access to medical marijuana for two years. He gave up access to medical marijuana, went on anxiety medication and completed his probation and later went back to using medical marijuana.

One of the public defenders working on Walton’s case, Cayne Duncan, in his brief, wrote that the judge is supposed to look at the facts of medical marijuana enrollment. He further wrote that the judge would be abusing the court’s powers by issuing a requirement for a doctor to present the facts written in the letter.

The district attorney defended the ruling saying that the judge acted within the authority, which stipulates that a doctor should appear and testify on the need for medical marijuana by the patient.

A case challenging the requirement for a doctor to testify in support of a convict’s need to continue using medical marijuana as they serve their probationary period is now before the State Supreme Court. Marijuana industry experts believe that companies like ChineseInvestors.com Inc. (OTCQB: CIIX) and MustGrow Biologics Corp. (CSE: MGRO) will be hoping that the highest court in the state removes the added requirements for people on parole who want to use medical marijuana to manage their health conditions.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Achieves Record Revenues for Q1 Fiscal Year 2020

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced its financial and operational summary for the first quarter of its fiscal year 2020. According to the update, total revenue for Q1FY2020 was $1,956,960, which is a 174.7% increase from $712,360 for the same quarter in the prior year. In addition, hemp and CBD sales revenues for Q1FY2020 were $948,751, a 569.2% increase from $141,764 for the same quarter in the prior year. “Fiscal Year 2020 is off to a great start evidenced by continued growth in both the company’s core business and its industrial hemp/CBD product business,” CIIX CEO Warren Wang said in the news release. “Following the 2018 cryptocurrency crash, the company re-focused on its core business, including providing investor relations services for other companies, especially those requiring Mandarin language support, and continued to implement its strategic plans for expansion of CBD Biotechnology Co. Ltd.’s, industrial hemp/CBD product lines in China evidenced by new product launches and initiatives taken to expand geographically in the Asian market.”

To view the full press release, visit http://cnw.fm/b3oX3

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Texas Inexplicably Halts Medical Cannabis Dispensary Licensing Process

The Texas Department of Public Safety suspended the permit application process for medical marijuana dispensaries without warning.

According to the Department of Compassionate Use Program website, the department is currently not accepting any applications. Initially, the state had said that the application process would remain open from October 1 to November 1.

This announcement was quite a shock to advocacy groups that were looking to see the implementation of the expanded medical cannabis program since the list of qualifying conditions was expanded by the legislature to include ALS (amyotrophic lateral sclerosis), terminal cancer, autism, and seizures disorders. Initially, medical marijuana was used to treat only people with intractable epilepsy who fulfilled certain requirements.

The Department of Public Safety in Texas did not explain as to why the permit application process was halted.

The agency spokesperson wrote in an email saying that as the department works through the recent changes in the legislature regarding the program, it is assessing the dispensing capacity of the current license holders while checking if there is a need for additional medical marijuana dispensary licenses.

During the period which the application was to be open (October-November), the number of companies applying for the license was expected to be high. In 2017, among the 43 applicants who applied for the preliminary permits, only three were accepted. This included Surterra Texas, Cansortium, Texas, and Compassionate Cultivation.

According to the executive director of Texas NORML, Jax Finkel, the termination of the application process was a letdown as many patients were looking forward to comparing prices for a better deal on the CBD products once the licenses were approved. More permits meant the patients would access medical marijuana affordably.

Finkel further said that medical marijuana is expensive, and many patients pay thousands of dollars out of their pocket for the drug since insurance and Medicare do not provide cover for marijuana products. Competition would be stiff after issuing additional licenses which would promote a drop in the price of CBD products.

Finkel added that it is alarming for the state to suspend the application process a week into the process without warning or communication to the doctors, patients and the general public.

On Wednesday, the state Assembly representative Stephanie Klick who led the last legislative session to expand the Compassionate Use Act, said that the suspension of the application process is probably a temporary delay.

Experts believe the cannabis industry, including actors like MustGrow Biologics Corp. (CSE: MGRO) and ChineseInvestors.com Inc. (OTCQB: CIIX), could be disturbed that a process to give patients more options has been derailed.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Takes Aim at National Hemp-Derived CBD Market Forecasted to Reach $7 Billion by 2023

ChineseInvestors.com (OTCQB: CIIX), an established financial news and investment portal for the global Chinese-speaking community, recently attended the MicroCap Conference at the Essex House in New York. CIIX subsidiary Biotech CBD Inc. CFO Alex Hamilton gave the company’s presentation (http://cnw.fm/x5iZm). An article discussing the company reads, “The conference was designed to bring together high-level institutional and retail investors with publicly held small- and micro-cap companies. Wang noted that he is optimistic about the long-term growth of CBD sales and said that, moving forward, the company plans to focus on cosmetics in the category. According to New Frontier Data, the U.S. hemp-CBD market is expected to triple in value by 2022. Likewise, according to Hemp Industry Daily market projections, the national market for hemp-derived CBD is expected to balloon to $7 billion by 2023 (http://cnw.fm/aHK7u).”

To view the full article, visit http://cnw.fm/2Gpkc

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Key Details of the Massachusetts Marijuana Home Delivery System

Very soon, residents of Massachusetts may begin enjoying marijuana home delivery. New rules allowing marijuana companies to delivery cannabis direct to their customers were approved last week by the Massachusetts Cannabis Control Commission. After they were adopted, the commission created new licenses for companies specializing in marijuana delivery.

According to the Cannabis Control Commission (CCC), home delivery for medical marijuana patients had already been approved. However, the 2016 ballot measures do provide for legalization of recreational marijuana home delivery; allowing it would give marijuana companies a chance to enter a market that is controlled by black market operators.

Britte McBride, CCC Commissioner, wrote an opinion piece for CommonWealth Magazine that marijuana is here to stay. He added that licensed companies, which are regulated and tax-paying businesses, are in open competition with illegal home delivery. To curb the operation of illicitly delivered marijuana, the commission has come up with legislation (pending) to authorize monetary sanctions against unlicensed and unregulated businesses.

During the first two years, only those in the social equity program and locally owned businesses approved for home delivery will be given licenses.

To promote small and minority businesses, the commission issued two-year exclusive licenses, which will be effective immediately after the permit is issued, especially after seeing how black and Latino communities were affected by the war on drugs. After noting that to start a delivery company required little startup capital, the officials encouraged small entrepreneurs to participate.

Social equity program applicants must be residents of a community that qualifies for economic empowerment. Their income should also be below 40% of the federal poverty levels.

The new rules require marijuana delivery companies to enter into a contract with a licensed retailer if they are transporting other people’s products.

For home delivery, the customer has to confirm that they are 21 years or older at the dispensary and again when cannabis is delivered. Deliveries should only be done between 8 a.m. and 9 p.m., and the delivery people will be monitored by GPS and body cameras to make sure orders are delivered to the right place, and for the security of the employee.

Although cash payments are permitted, businesses are urged to implement an electronic or online payment system. The new rules prohibit carrying marijuana worth more than $10,000 at a time, to help minimize theft.

Deliveries will not be permitted in colleges or any university housing, shelters, hotels, or government-subsidized housing. Customers should order only from their place of residence. Also, deliveries will not be made in those parts of Massachusetts that do not permit the sale of marijuana.

To start companies to offer delivery services, the state and local officials have to approve delivery licenses, said Steve Hoffman, CCC chairman. However, first, they need to put the application form on their site, which will take several months since the commission isn’t accepting applications as yet.

Experts believe that the entire cannabis industry, including companies like MustGrow Biologics Corp. (CSE: MGRO) and ChineseInvestors.com Inc. (OTCQB: CIIX) is glad that people in Massachusetts will soon enjoy marijuana home delivery.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Announces CBD Biotech, Inc.’s Expansion with Products Now Available In Seven New Major Asian Markets

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced expansion of its subsidiary, CBD Biotech, Inc., into six new countries and a new region of China via Shopee, its newest sales channel. Shopee, which launched in 2015, is now the largest e-commerce platform in Southeast Asia with more than 4 million registered businesses, 200 million app downloads, 30 million social media fans and over 7 million active buyers. Southeast Asia’s e-commerce market is expected to reach $240 billion by 2025 according to Google and Temasek’s Southeast Asia Internet Economy Report. “This dynamic and very popular platform in Southeast Asia, has allowed CBD Biotech to execute on our plans for expansion throughout Asia,” CBD Biotech Chief Financial Officer Alex Hamilton said in the news release. “Thanks to Shopee, we are now in seven new major markets: Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines and Taiwan, China.”

To view the full press release, visit http://cnw.fm/K3M2j

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) Focusing on CBD-Based Nutrition, Health Products

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX), through its division CBD Biotech Inc., is concentrating on cannabidiol (CBD)-based nutrition and health products. An article discussing the company reads, “CIIX recently announced that CBD Biotech launched six new products in combination with its long-term strategic plans to expand its hemp/CBD skincare offerings. CBD Biotech’s new products include CBD Oligopeptides Repair Eye Cream, CBD Nerve Acylamide Eye Essence, CBD Hemp Eye Mask, CBD Gold Nicotinamide Essence, CBD Handmade Horse Oil Soap and CBD Clear Bright. These products are designed to complement the company’s present skincare lines and increase brand loyalty and awareness.”

To view the full article, visit http://cnw.fm/z6bBp

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Support for Cannabis Legalization Bill Grows in Colombia

Colombia’s legislature will soon consider a bill to legalize recreational marijuana for adults. The proposed law is being filed by Gustavo Bolivar, a senator belonging to the Colombia Humana Party, one of the many opposition parties in the country.

The mover of the bill sees the law as a way to curb crime and support a drug policy shift to a direction in which drugs are looked at as public health concerns rather than as matters of law enforcement.

Bolivar has authored several books on drug trafficking and he sees the new bill as something that will facilitate “regularization and not legalization” of adult-use marijuana. In this law, marijuana would be regulated in the same way that tobacco and alcohol are regulated. There would be stiff penalties imposed on those who sell marijuana to minors, and marijuana smoking would be outlawed in public spaces.

The opposition senator referred to Canada, Uruguay and several states in the U.S. where recreational marijuana is legal as examples of jurisdictions where Colombia can learn as it drafts its own law to end prohibition.

The experience in those jurisdictions shows that drug-related crime levels reduce once marijuana is legalized, he added.

Sen. Alberto Castilla Salazar, another opposition senator who heads a leftist coalition, also revealed that he supports the bill to legalize recreational marijuana. Salazar insists that the country should end prohibition in order to break the control that criminal gangs have had over marijuana in favor of government control and regulation.

Former President Juan Manuel Santos has also expressed his support for the legalization of recreational marijuana. His Liberal Party may be instrumental in determining the success of the proposed law since the way party members vote may tilt the vote one way or the other.

While center-left and leftist members of the legislature appear to be united in support of the policy measure to legalize recreational marijuana, the move will go head to head with President Ivan Duque. Last year, the president signed a decree outlawing low-level possession of cocaine and marijuana. He took this step despite court rulings that such possession was legal.

However, the president’s party only has a minority of senators in the legislature, and some of them support the legalization effort. It therefore remains to be seen how many of his party members support his position of continuing marijuana prohibition.

Industry analysts are of the view that companies like ChineseInvestors.com Inc. (OTCQB: CIIX) and Earth Science Tech Inc. (OTCQB: ETST) see these winds of change in different countries as inevitable since more is being learned about the benefits of marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – ChineseInvestors.com Inc. (CIIX) to Present at the MicroCap Conference in New York City on September 17

Established financial news and investment portal for the global Chinese-speaking community ChineseInvestors.com (OTCQB: CIIX) today announced that CFO Alex P. Hamilton of its subsidiary, CBD Biotech, Inc., is scheduled to present at the MicroCap Conference. The exclusive event, dedicated to connecting small and micro-cap companies with high-level, institutional and retail investors, is slated to be held at the JW Marriot Essex House in New York City on September 16 -17, 2019. CIIX’s presentation is scheduled for Tuesday, September 17, 2019, at 1:00 p.m. Eastern Time in Room 1.

To view the full press release, visit http://cnw.fm/Nh76h

About ChineseInvestors.com

Founded in 1999, ChineseInvestors.com endeavors to be an innovative company providing: (a) real-time market commentary, analysis and educational-related services in Chinese language character sets (traditional and simplified); (b) advertising and public relations-related support services; and (c) retail, online and direct sales of hemp-based products and other health and wellness products. For more information, visit the company’s website at www.ChineseInvestors.com.

NOTE TO INVESTORS: The latest news and updates relating to CIIX are available in the company’s newsroom at http://cnw.fm/CIIX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com